Found: 2
Select item for more details and to access through your institution.
Outcome after short exposure to tyrosine kinase inhibitors in pregnant female patients with chronic myeloid leukemia.
- Published in:
- Journal of Hematology & Oncology, 2024, v. 17, n. 1, p. 1, doi. 10.1186/s13045-024-01603-z
- By:
- Publication type:
- Article
Safety and efficacy of jaktinib (a novel JAK inhibitor) in patients with myelofibrosis who are relapsed or refractory to ruxolitinib: A single‐arm, open‐label, phase 2, multicenter study.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. 1579, doi. 10.1002/ajh.27031
- By:
- Publication type:
- Article